Aqr Capital Management LLC Cue Biopharma, Inc. Transaction History

Aqr Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$1.72 - $3.1 $2,643 - $4,764	-1,537 Reduced 6.44%	22,340 $58,000
Q3 2023 Nov 14, 2023	BUY	$2.23 - $4.69 $53,245 - $111,983	23,877 New	23,877 $54,000
Q1 2021 May 17, 2021	SELL	$11.2 - $16.09 $350,313 - $503,263	-31,278 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$11.12 - $16.4 $62,183 - $91,708	-5,592 Reduced 15.17%	31,278 $391,000
Q3 2020 Nov 16, 2020	BUY	$15.05 - $23.54 $232,612 - $363,834	15,456 Added 72.18%	36,870 $555,000
Q2 2020 Aug 17, 2020	SELL	$12.7 - $30.73 $6,400 - $15,487	-504 Reduced 2.3%	21,414 $525,000
Q1 2020 May 15, 2020	BUY	$9.85 - $22.27 $215,892 - $488,113	21,918 New	21,918 $311,000

14.1M

14.4K

2.6K

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $38.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Aqr Capital Management LLC with notifications on news.